Literature DB >> 2877644

Relaxation therapy for hypertension. Comparison of effects with concomitant placebo, diuretic, and beta-blocker.

R G Jacob, A P Shapiro, R A Reeves, A M Johnsen, R H McDonald, P C Coburn.   

Abstract

We compared the effects of relaxation therapy in hypertensive patients taking placebo, a beta-blocker (atenolol, 100 mg/d), or a diuretic (chlorthalidone, 50 mg/d), and we also compared the effects of relaxation therapy with the effects of the latter two drugs alone. Blood pressures were measured not only in the relaxation therapists' office and at a hypertension clinic, but also in the patient's environment by means of 24-hour ambulatory blood pressure recordings. The effect of relaxation therapy, while statistically significant, was modest. There was no generalization of effect to ambulatory blood pressure. Atenolol was significantly more effective than relaxation in reducing both systolic and diastolic pressure. Chlorthalidone was significantly more effective than relaxation in reducing systolic but not diastolic pressure in the hypertension clinic only. The long-term effects of relaxation were independent of concomitant drug use, but within the actual relaxation sessions blood pressure dropped further during chlorthalidone than during placebo or atenolol treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877644     DOI: 10.1001/archinte.146.12.2335

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  Interaction of biofeedback-assisted relaxation and diuretic in treatment of essential hypertension.

Authors:  I E Jurek; J T Higgins; A McGrady
Journal:  Biofeedback Self Regul       Date:  1992-06

Review 2.  Stress management techniques: are they all equivalent, or do they have specific effects?

Authors:  P M Lehrer; R Carr; D Sargunaraj; R L Woolfolk
Journal:  Biofeedback Self Regul       Date:  1994-12

Review 3.  Non-pharmacologic measures for lowering blood pressure.

Authors:  K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.